Effect of ischemic postconditioning in correction of tetralogy of Fallot

International Heart Journal

Volumn 52, Issue 5, 2011, Pages 312-317

  Ji, Qiang ^a   Mei, Yunqing ^a   Wang, Xisheng ^a   Feng, Jing ^a   Wusha, Dewei ^b   Cai, Jianzhi ^a   Zhou, Yongxin ^a  

^a TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Ischemia reperfusion injury; Ischemic postconditioning; Tetralogy of Fallot; Trials

Indexed keywords

TROPONIN I;

AORTA CLAMPING; ARTICLE; CARDIOPLEGIA; CHILD; CONTROLLED STUDY; EXTUBATION; FALLOT TETRALOGY; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART OUTPUT; HEART PROTECTION; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; ISCHEMIC POSTCONDITIONING; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY;

CARDIAC OUTPUT; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; INFANT; ISCHEMIC POSTCONDITIONING; MALE; MYOCARDIAL REPERFUSION INJURY; OXYGEN; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STROKE VOLUME; TETRALOGY OF FALLOT; TROPONIN I; VENTRICULAR FUNCTION, LEFT;

EID: 80054726698     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.52.312     Document Type: Article

References (14)

1. Kloner RA, Rezkalla SH. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res 2006; 70: 297-307. (Review)
2. Granfeldt A, Lefer DJ, Vinten-Johansen J. Protective ischemia in patients: preconditioning and postconditioning. Cardiovasc Res 2009; 83: 234-46. (Review)
3. Zhao ZQ, Corvera JS, Alkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Phys-iol 2003; 285: H579-88.
4. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reper-fusion induced injury. Cardiovasc Res 2006; 70: 200-11. (Review)
5. Crisostomo PR, Wairiuko GM, Wang M, Tsai BM, Morrell ED, Meldrum DR. Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J Am Coll Surg 2006; 202: 797-812. (Review)
6. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation 2005; 112: 2143-8. (Review)
7. Laskey WK. Brief repetitive balloon occlusions enhance reper-fusion during percutaneous coronary intervention for acute myo-cardial infarction: a pilot study. Catheter Cardiovasc Interv 2005; 65: 361-7.
8. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis 2009; 204: 334-41. (Review)
9. Luo W, Li B, Lin G, Huang R. Postconditioning in cardiac surgery for tetralogy of Fallot. J Thorac Cardiovasc Surg 2007; 133: 1373-4.
10. Ji Q, Mei Y, Wang X, et al. Combination of irbesartan and amio-darone to maintain sinus rhythm in patients with persistent atrial fibrillation after rheumatic valve replacement. Circ J 2010; 74: 1873-9.
11. Jin ZX, Zhou JJ, Xin M, et al. Postconditioning the human heart with adenosine in heart valve replacement surgery. Ann Thorac Surg 2007; 83: 2066-72.
12. Downey JM, Cohen MV. Why do we still not have cardioprotec-tive drugs? Circ J 2009; 73: 1171-7. (Review)
13. Imura H, Caputo M, Parry A, Pawade A, Angelini GD, Suleiman MS. Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery. Circulation 2001; 103: 1551-6.
14. Klatte K, Chaitman BR, Theroux P, et al. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. J Am Coll Cardiol 2001; 38: 1070-7.